X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

Singapore – Sweden Research Offers Stem Cell Vision Recovery

Content Team by Content Team
18th April 2023
in Drug Development, News
Singapore – Sweden Research Offers Stem Cell Vision Recovery

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Preclinical study making use of stem cells to develop progenitor photoreceptor cells-light detecting cells found in the eye and thereafter transplanting these cells into experimental models of damaged retinas has led to a significant recovery of the vision.

The findings happen to be from scientists at Duke-NUS Medical School, the Karolinska Institute in Sweden, and the Singapore Eye Research Institute, and they mark the first step towards probably restoring vision when it comes to eye diseases that are characterised by photoreceptor loss. The degeneration of the photoreceptor in eye happens to be a prominent cause when it comes to deteriorating vision that eventually causes blindness, for which there is no effective treatment at present.

Photoreceptor degeneration happens to be in a variety of retinal diseases that are inherited, like retinitis pigmentosa, which is a rare eye disease that breaks down cells in the retina with time and leads to vision loss, as well as age-related degeneration of macular which is a leading reason for global vision impairment.

Moving forward, the team is hoping to refine their set of methodologies so as to make the process seamless and achieve more consistent outcomes as compared to the attempts that have been made before in order to explore the therapy of stem cells in the case of photoreceptor cell replacement.

According to Professor Karl Tryggvason from the Duke-NUS Cardiovascular and Metabolic Disorder Programme, who also happens to be the co-author of the study, if they happen to get results that look promising in their future studies, they hope to take the next step of moving towards clinical trials in patients, which would indeed be a significant step in reversing the damage to the retina and hence thereby restore the vision.,

Previous Post

Brain Tumour In Mice Gets A Hope of Traditional Chinese Drug

Next Post

Next Decade To Witness Automation Driving Biopharma Sector

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Next Decade To Witness Automation Driving Biopharma Sector

Next Decade To Witness Automation Driving Biopharma Sector

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In